Seres Therapeutics, Inc.MCRBNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P8
Near historical low
vs 5Y Ago
-1.8x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | -24.06% |
| 2024 | -45.07% |
| 2023 | 7.25% |
| 2022 | -22.72% |
| 2021 | 56.66% |
| 2020 | 13.01% |
| 2019 | -16.48% |
| 2018 | 7.27% |
| 2017 | 9.11% |
| 2016 | 115.22% |